Loading
Thoracic oncologist who leads NCC Hospital in Tokyo and has been a Japanese principal investigator on a generation of lung cancer trials.
Yuichiro Ohe is Director of the National Cancer Center Hospital in Tokyo and a thoracic oncologist. He has been a Japanese principal investigator on a generation of lung cancer trials, leading Japanese participation in EGFR, ALK and immunotherapy studies in non-small-cell and small-cell lung cancer. His publications include the FLAURA trial of osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. He directs the hospital while continuing work on lung cancer chemotherapy, targeted therapy and clinical trials.
| Title | Journal | Year |
|---|---|---|
| Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer (FLAURA) | NEJM | 2018 |
Shares Japanese Society of Medical Oncology, Non-small-cell lung cancer.
Shares Japanese Society of Medical Oncology, National Cancer Center Hospital, Osimertinib, Small-cell lung cancer.
Shares Osimertinib, Small-cell lung cancer, Non-small-cell lung cancer.
Shares Osimertinib, Small-cell lung cancer, Non-small-cell lung cancer.
Shares Osimertinib, Small-cell lung cancer, Non-small-cell lung cancer.
Shares Osimertinib, Small-cell lung cancer, Non-small-cell lung cancer.
Shares Osimertinib, Small-cell lung cancer, Non-small-cell lung cancer.
Shares Osimertinib, Small-cell lung cancer, Non-small-cell lung cancer.